MYSEUM INC (MYSE) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MYSE • US23816M2061

1.82 USD

-0.07 (-3.7%)

Last: Jan 30, 2026, 08:07 PM

Fundamental Rating

Taking everything into account, MYSE scores 2 out of 10 in our fundamental rating. MYSE was compared to 278 industry peers in the Software industry. While MYSE seems to be doing ok healthwise, there are quite some concerns on its profitability. MYSE has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MYSE has reported negative net income.
In the past year MYSE has reported a negative cash flow from operations.
In the past 5 years MYSE always reported negative net income.
In the past 5 years MYSE always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of MYSE (-70.05%) is worse than 89.21% of its industry peers.
Looking at the Return On Equity, with a value of -56.83%, MYSE is doing worse than 71.22% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-70.05%
ROE	-56.83%
ROIC	N/A

ROA(3y)-100.23%

ROA(5y)-97.03%

ROE(3y)-98.69%

ROE(5y)-103.79%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYSE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MYSE has been increased compared to 1 year ago.
Compared to 5 years ago, MYSE has more shares outstanding
MYSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MYSE has an Altman-Z score of -16.64. This is a bad value and indicates that MYSE is not financially healthy and even has some risk of bankruptcy.
MYSE has a worse Altman-Z score (-16.64) than 91.37% of its industry peers.
MYSE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
MYSE has a better Debt to Equity ratio (0.00) than 66.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-16.64

ROIC/WACCN/A

WACC11.08%

2.3 Liquidity

MYSE has a Current Ratio of 5.72. This indicates that MYSE is financially healthy and has no problem in meeting its short term obligations.
MYSE's Current ratio of 5.72 is amongst the best of the industry. MYSE outperforms 88.85% of its industry peers.
A Quick Ratio of 5.72 indicates that MYSE has no problem at all paying its short term obligations.
MYSE has a Quick ratio of 5.72. This is amongst the best in the industry. MYSE outperforms 88.85% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.72
Quick Ratio	5.72

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.09% over the past year.
MYSE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 20.00%.

EPS 1Y (TTM)35.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%32.65%

Revenue 1Y (TTM)20%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%200%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.